Arvin Yang

Immune checkpoint therapy—current perspectives and future directions

Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides

Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results.

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.